PL366170A1 - Nowe kompozycje - Google Patents

Nowe kompozycje

Info

Publication number
PL366170A1
PL366170A1 PL99366170A PL36617099A PL366170A1 PL 366170 A1 PL366170 A1 PL 366170A1 PL 99366170 A PL99366170 A PL 99366170A PL 36617099 A PL36617099 A PL 36617099A PL 366170 A1 PL366170 A1 PL 366170A1
Authority
PL
Poland
Prior art keywords
novel compositions
compositions
novel
Prior art date
Application number
PL99366170A
Other languages
English (en)
Other versions
PL200840B1 (pl
Inventor
Randall K. Johnson
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22199389&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL366170(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of PL366170A1 publication Critical patent/PL366170A1/pl
Publication of PL200840B1 publication Critical patent/PL200840B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
PL366170A 1998-05-21 1999-05-20 Kompozycje, kompozycja farmaceutyczna, sposób wytwarzania kompozycji oraz zastosowania kompozycji i zastosowania polipeptydu PL200840B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8656098P 1998-05-21 1998-05-21

Publications (2)

Publication Number Publication Date
PL366170A1 true PL366170A1 (pl) 2005-01-24
PL200840B1 PL200840B1 (pl) 2009-02-27

Family

ID=22199389

Family Applications (1)

Application Number Title Priority Date Filing Date
PL366170A PL200840B1 (pl) 1998-05-21 1999-05-20 Kompozycje, kompozycja farmaceutyczna, sposób wytwarzania kompozycji oraz zastosowania kompozycji i zastosowania polipeptydu

Country Status (27)

Country Link
US (1) US6582689B1 (pl)
EP (1) EP1079818B1 (pl)
JP (1) JP4283998B2 (pl)
KR (1) KR100624588B1 (pl)
CN (1) CN1227027C (pl)
AR (1) AR019844A1 (pl)
AT (1) ATE245440T1 (pl)
AU (1) AU750918B2 (pl)
BR (1) BR9910622A (pl)
CA (1) CA2328603A1 (pl)
CO (1) CO5050337A1 (pl)
CZ (1) CZ300496B6 (pl)
DE (1) DE69909781T2 (pl)
DK (1) DK1079818T3 (pl)
ES (1) ES2204164T3 (pl)
GC (1) GC0000102A (pl)
HU (1) HUP0600520A2 (pl)
IL (2) IL139733A0 (pl)
MY (1) MY123434A (pl)
NO (1) NO329195B1 (pl)
NZ (1) NZ508115A (pl)
PL (1) PL200840B1 (pl)
PT (1) PT1079818E (pl)
TR (1) TR200003453T2 (pl)
TW (1) TWI227136B (pl)
WO (1) WO1999059565A1 (pl)
ZA (1) ZA200006675B (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1392830T3 (da) 2001-03-08 2006-05-08 Ares Trading Sa Interleukin-18 mutanter, deres fremstilling og anvendelse
US20050079153A1 (en) * 2002-08-14 2005-04-14 Pfizer Inc. Methods for enhancing immune functions in neonatal mammals by administration of IL-18
EP1572228A4 (en) * 2002-09-19 2009-03-04 Centocor Inc METHOD FOR THE INTRODUCTION OF THE TREATMENT OF DENDRITIC CELLS AND ITS USES
CN101039696B (zh) * 2004-08-20 2011-08-17 史密丝克莱恩比彻姆公司 给药人il-18治疗创伤的方法
US20100061958A1 (en) 2006-09-14 2010-03-11 The Trustees Of The University Of Pennsylvania Modulation of Regulatory T Cells by Human IL-18
AR065803A1 (es) * 2007-03-23 2009-07-01 Smithkline Beecham Corp Uso de un polipeptido de il- 18 humana y un anticuerpo anti- cd para preparar unmedicamento
GB0803352D0 (en) 2008-02-22 2008-04-02 Ntnu Technology Transfer As Oligopeptidic compounds and uses thereof
US8168165B2 (en) * 2008-12-23 2012-05-01 Abbott Laboratories Alkylated interleukin-18 compositions
TW201506402A (zh) * 2013-08-15 2015-02-16 Tonyar Biotech Inc 自體防潮的檢驗芯片及其製造方法
SG11202001384TA (en) * 2017-09-06 2020-03-30 Univ Yale Interleukin-18 variants and methods of use
CA3197145A1 (en) 2020-11-02 2022-05-05 Aaron RING Interleukin-18 variants and methods of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2697752B1 (fr) * 1992-11-10 1995-04-14 Rhone Poulenc Rorer Sa Compositions antitumorales contenant des dérivés du taxane.
JP4004088B2 (ja) * 1995-09-26 2007-11-07 株式会社林原生物化学研究所 免疫担当細胞においてインターフェロン−γの産生を誘導する蛋白質
US6207641B1 (en) * 1995-03-10 2001-03-27 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Pharmaceutical composition containing IFN-γ inducing polypeptide or factor for treating and/or preventing IFN-γ susceptive diseases
TW581771B (en) 1994-11-15 2004-04-01 Hayashibara Biochem Lab Recombinant production of a polypeptide for inducing interferon-gamma production, and monoclonal antibody against the polypeptide
US5869535A (en) * 1995-03-21 1999-02-09 The Board Of Trustees Of The University Of Illinois Method and composition for selectively inhibiting melanoma
JP4024366B2 (ja) * 1996-11-29 2007-12-19 株式会社林原生物化学研究所 ポリペプチド

Also Published As

Publication number Publication date
EP1079818A4 (en) 2001-12-12
HUP0600520A2 (en) 2006-10-28
JP4283998B2 (ja) 2009-06-24
IL139733A (en) 2009-06-15
JP2003509333A (ja) 2003-03-11
KR100624588B1 (ko) 2006-09-18
EP1079818B1 (en) 2003-07-23
TR200003453T2 (tr) 2001-10-22
CN1367686A (zh) 2002-09-04
AU750918B2 (en) 2002-08-01
PT1079818E (pt) 2004-02-27
DE69909781D1 (de) 2003-08-28
NO20005857D0 (no) 2000-11-20
AR019844A1 (es) 2002-03-20
BR9910622A (pt) 2001-01-30
CA2328603A1 (en) 1999-11-25
MY123434A (en) 2006-05-31
CN1227027C (zh) 2005-11-16
US6582689B1 (en) 2003-06-24
NZ508115A (en) 2003-12-19
HK1035136A1 (en) 2001-11-16
EP1079818A1 (en) 2001-03-07
IL139733A0 (en) 2002-02-10
ZA200006675B (en) 2002-02-27
GC0000102A (en) 2005-06-29
WO1999059565A1 (en) 1999-11-25
PL200840B1 (pl) 2009-02-27
TWI227136B (en) 2005-02-01
CO5050337A1 (es) 2001-06-27
ES2204164T3 (es) 2004-04-16
DE69909781T2 (de) 2004-05-27
CZ300496B6 (cs) 2009-06-03
ATE245440T1 (de) 2003-08-15
DK1079818T3 (da) 2004-04-19
NO20005857L (no) 2000-11-21
CZ20004321A3 (en) 2001-05-16
KR20010052369A (ko) 2001-06-25
NO329195B1 (no) 2010-09-13
AU4309499A (en) 1999-12-06

Similar Documents

Publication Publication Date Title
AP2000001874A0 (en) Cellecoxib compositions
GB9917982D0 (en) Compositions
GB9811377D0 (en) Compositions
GB9924268D0 (en) Compositions
GB9828861D0 (en) Compositions
IL139733A0 (en) Novel compositions
GB9905325D0 (en) Compositions
GB9809507D0 (en) Novel composition
GB2339693B (en) Anti-mollusc compositions
GB9827291D0 (en) Compositions
GB0016470D0 (en) Compositions
GB9905746D0 (en) Compositions
GB9812818D0 (en) Dentfrice compositions
GB2336535B (en) Compositions
GB9809347D0 (en) Compositions
GB9816050D0 (en) Compositions
GB9827690D0 (en) Compositions
GB9818278D0 (en) Compositions
GB9809121D0 (en) Novel compositions
GB9810421D0 (en) Novel compositions
GB9816423D0 (en) Novel compositions
GB9824924D0 (en) Odour-neutralising compositions
GB9805084D0 (en) Compositions
GB9824922D0 (en) Odour-neutralising compositions
GB9817459D0 (en) Compositions

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20140520